4
Total investments
2
Early stage
1
Mid stage
1
Late stage
3y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Feb 2026
Were developing a category defining neurotech platform that uses next-generation ultrasound technology to non-invasively treat and interface with the brain. Our approach uses precisely focused sound waves to safely modulate specific brain circuits, establishing a new paradigm for non-invasive brain-computer interaction and therapeutic intervention. Transcranial ultrasound technology shows remarkable promise, not only for treating neurological and psychiatric conditions but also as a foundation for next-generation neuromodulation applications.
Our founding team combines expertise in ultrasound engineering and clinical neuroscience from world-leading institutions in medical technology and brain science. Were combining cutting-edge engineering with deep neuroscientific understanding to build what could become the gold standard for non-invasive neuromodulation, potentially transforming the lives of millions affected by brain disorders while opening new frontiers in brain-computer interaction.
Angel Investor
Mar 2025
Resonant Link Medical is an innovative medical technology company redefining wireless power and data transfer for implantable medical devices to help people get well and stay well.
Resonant Link Medical’s unmatched technology platform Aurion WPT™ delivers uninterrupted wireless power thats up to 10x faster than conventional wireless over double the range. The platform combines core innovations in coils, power electronics, magnetics, and data transfer capabilities to enable smaller, smarter, and longer-lasting devices that advance how we treat chronic conditions and make new therapies possible for the first time.
If youre looking for unprecedented power performance and a faster, lower-risk path to market, reach out to info@rlmedical.com to learn whats possible for your device.
Angel Investor
Mar 2025
At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible.
Angel Investor
Jun 2023
Vistim Labs mission is to enable clinicians to offer instant, in-clinic brain monitoring with similar insights as PET, CSF, and cognitive testing, for monitoring neurodegenerative disease progression.
Our mission is give doctors the means to cure devastating diseases like Alzheimers, by providing a feedback loop to know when treatments are working.
We are valued for our ability to correlate across all relevant biomarkers in a single EEG. Research shows that our technology is capable of generating full-resolution PET imaging with exceptional concordance. Very high correlation with endpoints like: cognitive performance, amyloid & tau accumulation, alpha-synuclein, and neurodegeneration.
As far as we know, we are the only EEG technology in the world with research demonstrating structural brain-imaging capabilities.
Experience · 7 entries
All (7)
Investments (4)
Founder (2)
2026
Angel Investor
Feb 2026
Were developing a category defining neurotech platform that uses next-generation ultrasound technology to non-invasively treat and interface with the brain. Our approach uses precisely focused sound waves to safely modulate specific brain circuits, establishing a new paradigm for non-invasive brain-computer interaction and therapeutic intervention. Transcranial ultrasound technology shows remarkable promise, not only for treating neurological and psychiatric conditions but also as a foundation for next-generation neuromodulation applications.
Our founding team combines expertise in ultrasound engineering and clinical neuroscience from world-leading institutions in medical technology and brain science. Were combining cutting-edge engineering with deep neuroscientific understanding to build what could become the gold standard for non-invasive neuromodulation, potentially transforming the lives of millions affected by brain disorders while opening new frontiers in brain-computer interaction.
Venture Partner
Jan 2026
Jumpspace Ventures is an early stage venture capital firm committed to driving innovation in neurotech and healthcare related deep tech.
2025
Angel Investor
Mar 2025
Resonant Link Medical is an innovative medical technology company redefining wireless power and data transfer for implantable medical devices to help people get well and stay well.
Resonant Link Medical’s unmatched technology platform Aurion WPT™ delivers uninterrupted wireless power thats up to 10x faster than conventional wireless over double the range. The platform combines core innovations in coils, power electronics, magnetics, and data transfer capabilities to enable smaller, smarter, and longer-lasting devices that advance how we treat chronic conditions and make new therapies possible for the first time.
If youre looking for unprecedented power performance and a faster, lower-risk path to market, reach out to info@rlmedical.com to learn whats possible for your device.
Angel Investor
Mar 2025
At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible.
2023
Founder CEO
Aug 2023
Your Cortical Avatar Technology.
At uCat, we combine Virtual Reality (VR), implanted Brain-Computer Interface (BCI), and Artificial Intelligence (AI) to create an accessible Metaverse for all.
Our VR system, "uCat", celebrates the achievements of the many tetraplegic individuals who used brain implants to reclaim their movement and speech.
Achieved in breakthrough clinical trials, these pioneers demonstrated the real-time performance and clinical reliability of these implantable BCIs. However, these BCIs fall short of demonstrating usefulness to patients day-to-day activities.
Once you decode their intention to move or talk, what do you do with that data? Most think to control a robot or an exoskeleton and a speaker. Some think of moving a cursor on a screen. We think todays VR offers all of the above and some more.
In the eleventh hour, just as the first companies bring these systems to market, uCat enters to help the first paralyzed users feel independent inside the Metaverse - equal in expression and participation to anyone they meet.
Show all 7 entries ↓
Investment activity
2023–2026 · 4 investments
Recent (last 2 years)Earlier
